259 related articles for article (PubMed ID: 35205623)
1. Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma.
Rolf D; Reinartz G; Rehn S; Kittel C; Eich HT
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205623
[TBL] [Abstract][Full Text] [Related]
2. Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).
Reinartz G; Pyra RP; Lenz G; Liersch R; Stüben G; Micke O; Willborn K; Hess CF; Probst A; Fietkau R; Jany R; Schultze J; Rübe C; Hirt C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Möller P; Neubauer A; Wilhelm M; Willich N; Berdel WE; Eich HT
Strahlenther Onkol; 2019 Jun; 195(6):544-557. PubMed ID: 30859254
[TBL] [Abstract][Full Text] [Related]
3. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
[TBL] [Abstract][Full Text] [Related]
4. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
Schmelz R; Miehlke S; Thiede C; Brueckner S; Dawel M; Kuhn M; Ruskoné-Formestraux A; Stolte M; Jentsch C; Hampe J; Morgner A
J Gastroenterol; 2019 May; 54(5):388-395. PubMed ID: 30327875
[TBL] [Abstract][Full Text] [Related]
5. Renaissance of Radiotherapy in Intestinal Lymphoma? 10-Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow-up of Two German Multicenter Consecutive Prospective Phase II Trials.
Reinartz G; Molavi Tabrizi C; Liersch R; Ullerich H; Hering D; Willborn K; Schultze J; Micke O; Ruebe C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Moeller P; Neubauer A; Wilhelm M; Lenz G; Berdel WE; Willich N; Eich HT
Oncologist; 2020 May; 25(5):e816-e832. PubMed ID: 32219909
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
Fang P; Gunther JR; Pinnix CC; Dong W; Strati P; Nastoupil LJ; Steiner RE; Ahmed S; Damron EP; Fowler N; Nair R; Westin JR; Neelapu S; Ha CS; Dabaja BS
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1414-1420. PubMed ID: 33309978
[TBL] [Abstract][Full Text] [Related]
7. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
8. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
9. Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15.
MacManus MP; Roos D; O'Brien P; Capp A; Wirth A; Tsang R; Bressel M; Lade S; Seymour JF
Eur J Cancer; 2021 Jul; 152():129-138. PubMed ID: 34098462
[TBL] [Abstract][Full Text] [Related]
10. Anti-Helicobacter pylori therapy in localized gastric mucosa-associated lymphoid tissue lymphoma: A prospective, nationwide, multicenter study in Japan.
Sugizaki K; Tari A; Kitadai Y; Oda I; Nakamura S; Yoshino T; Sugiyama T
Helicobacter; 2018 Apr; 23(2):e12474. PubMed ID: 29504247
[TBL] [Abstract][Full Text] [Related]
11. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
12. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
[TBL] [Abstract][Full Text] [Related]
13. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of follicular lymphoma: updated role and new rules.
Yahalom J
Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
[TBL] [Abstract][Full Text] [Related]
15. [Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma)].
Takahashi T; Suzumiya J
Nihon Rinsho; 2014 Mar; 72(3):493-8. PubMed ID: 24724410
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma.
Kim SW; Lim DH; Ahn YC; Kim WS; Kim SJ; Ko YH; Kim KM
World J Gastroenterol; 2013 Sep; 19(36):6062-8. PubMed ID: 24106407
[TBL] [Abstract][Full Text] [Related]
18. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection.
Akamatsu T; Mochizuki T; Okiyama Y; Matsumoto A; Miyabayashi H; Ota H
Helicobacter; 2006 Apr; 11(2):86-95. PubMed ID: 16579838
[TBL] [Abstract][Full Text] [Related]
19. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
20. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
